Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications

Stem Cell Res Ther. 2018 Feb 26;9(1):44. doi: 10.1186/s13287-018-0773-9.

Abstract

In the past years, cardiac mortality has decreased, but cardiac diseases are still responsible for millions of deaths every year worldwide. Bone-marrow mesenchymal stem cells (BMSCs) transplantation may be a promising therapeutic strategy because of its capacity to differentiate into cardiac cells. Current research indicates that chemical substances, microRNAs, and cytokines have biological functions that regulate the cardiomyocytes differentiation of BMSCs. In this review, we chiefly summarize the regulatory factors that induce BMSCs to differentiate into cardiomyocytes.

Keywords: Bone marrow-derived mesenchymal stem cells; Cardiomyocytes; Cytokines; Differentiation; Microenvironment; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Marrow Cells / metabolism*
  • Bone Marrow Cells / pathology
  • Cell Differentiation*
  • Cytokines / metabolism
  • Heart Diseases* / metabolism
  • Heart Diseases* / pathology
  • Heart Diseases* / therapy
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells / metabolism*
  • Mesenchymal Stem Cells / pathology
  • MicroRNAs / metabolism
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology

Substances

  • Cytokines
  • MicroRNAs